Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dynein regulatory complex subunit 1 | 0.641 | 0.654 | 8.3E-20 |
|
disease | 0.800 | None | 0 | 2 | |||||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.700 | None | 0 | 0 | |||||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
phenotype | 0.600 | moderate | 0 | 1 | |||||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.600 | strong | 0 | 31 | |||||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.600 | None | 0 | 1 | ||||||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
phenotype | 0.600 | strong | 0 | 2 | |||||||||||
|
RAS related 2 | 0.656 | 0.500 | 0.97 |
|
disease | 0.600 | None | 0 | 1 | |||||||||||
|
tRNA | 0.590 | 0.731 |
|
disease | 0.600 | None | 0 | 1 | ||||||||||||
|
S-antigen visual arrestin | 0.570 | 0.731 | 1.5E-16 |
|
disease | 0.600 | limited | 0 | 1 | |||||||||||
|
calcium voltage-gated channel subunit alpha1 S | 0.595 | 0.692 | 6.3E-12 |
|
disease | 0.600 | moderate | 0 | 1 | |||||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.600 | limited | 0 | 1 | |||||||||||
|
cytochrome P450 family 24 subfamily A member 1 | 0.518 | 0.692 | 3.2E-23 |
|
phenotype | 0.600 | strong | 0 | 0 | |||||||||||
|
plastin 3 | 0.656 | 0.500 | 0.99 |
|
phenotype | 0.600 | strong | 0 | 3 | |||||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
disease | 0.600 | strong | 0 | 2 | |||||||||||
|
carbamoyl-phosphate synthase 1 | 0.590 | 0.615 | 1.1E-09 |
|
phenotype | 0.600 | limited | 0 | 3 | |||||||||||
|
RAD54 like | 0.633 | 0.423 | 2.4E-15 |
|
disease | 0.600 | None | 0 | 1 | |||||||||||
|
RAD54 homolog B | 0.659 | 0.462 | 8.1E-13 |
|
disease | 0.600 | None | 0 | 1 | |||||||||||
|
glutaredoxin and cysteine rich domain containing 2 | 0.861 | 0.115 | 1.0E-07 |
|
disease | 0.600 | None | 0 | 1 | |||||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.600 | strong | 0 | 4 | |||||||||||
|
cysteine rich with EGF like domains 1 | 0.670 | 0.269 | 1.3E-11 |
|
disease | 0.600 | None | 0 | 1 | |||||||||||
|
TOP1 binding arginine/serine rich protein | 0.659 | 0.538 | 1.00 |
|
disease | 0.600 | None | 0 | 2 | |||||||||||
|
metabolism of cobalamin associated D | 0.751 | 0.385 | 2.1E-05 |
|
disease | 0.600 | None | 0 | 3 | |||||||||||
|
tRNA nucleotidyl transferase 1 | 0.700 | 0.192 | 1.6E-04 |
|
disease | 0.600 | strong | 0 | 3 | |||||||||||
|
Rho GTPase activating protein 26 | 0.656 | 0.500 | 1.00 |
|
disease | 0.600 | limited | 0 | 1 | |||||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.600 | limited | 0 | 1 |